eloralintide tirzepatide A Study of (LY3841136) and Eloralintide With in Participants With Overweight or Obesity Eloralintide + Tirzepatide for Obesity
Description
Tirzepatide: A glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) dual agonist in development for the treatment of type 2 diabetes
Anterior cingulate taste activation predicts ad libitum intake of sweet and savory drinks in healthy, normal-weight men
discuss risks and benefits with your healthcare provider
The issue arose because weight-loss drugs slow gastric emptying
Heres what you need to know: Dont take tirzepatide (Mounjaro or Zepbound ) if you or anyone in your family has had: Medullary thyroid carcinoma (MTC) Multiple endocrine neoplasia syndrome type 2 (MEN 2) Also, avoid tirzepatide if youve previously had a serious allergic reaction to tirzepatide or any of its ingredients
Challenge 3: constipation Slowed gastric emptying combined with reduced food volume creates the perfect conditions for constipation
